The present invention relates to novel azabicyclo derivatives of Formula (I) as anti-inflammatory agents which are useful for inhibition and prevention of inflammation and associated pathologies including inflammatory and autoimmune diseases such as sepsis, rheumatoid arthritis, inflammatory bowel disease, type-1 diabetes, asthma, chronic obstructive pulmonary disorder, organ transplant rejection and psoriasis.
本发明涉及一种新型的Formula (I)的
氮杂双环衍
生物,作为抗炎药物,可用于抑制和预防炎症及相关病理,包括脓毒症、类风湿关节炎、炎症性肠病、1型糖尿病、哮喘、慢性阻塞性肺病、器官移植排斥反应和牛皮癣。